diagen oral bpc-157 Stable Gastric Pentadecapeptide BPC 157
Description
Cells 10, 47
With current Category 2 status, double-check that a pharmacy is allowed to sell it right now, and keep an eye on the FDAs July 2026 meeting
Common side effects include nausea, headache, dizziness, and insomnia
May support overall bone quality beyond just density measurements
